Delivery Order SPE2DB22D2108-SPE2DB24FU2RH
Award Date 11/1/23
Potential Completion Date 11/2/23
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $9,151.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract for the supply of BUPROPION HCL XL 300 MG TABLET 500S, with a completion date of February 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,854.28, is for the delivery of Bupropion HCL XL 300 mg tablets over the period ending on January 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $1,075.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,422,769 units of Bupropion HCL XL 300 mg tablets. This is a Firm Fixed Price Delivery Order contract with a completion date of July 7, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
- This contract award, valued at $29,606.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,323,524 units of Bupropion HCL XL 300 mg tablets, with a completion date of January 16, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $16,351.77, is a delivery order for the supply of Bupropion HCL XL 300 mg tablets. The award has a period of performance through February 1, 2024 and utilizes a firm-fixed price pricing structure. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,111.40, is for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a significant supplier of pharmaceutical products and...
- This federal contract award, valued at $11,422.42, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of Bupropion HCL XL 150 mg Tablets in 500-count bottles. This is a firm-fixed-price delivery order contract with a completion date of March 11, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $5,768.03 for the supply of 500 units of BUPROPION HCL XL 300 MG TABLET to the agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is not designated as a set-aside contract and was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $25,866.44, is for the delivery of Bupropion HCL XL 150 mg tablets over a 2-year period ending in May 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned, indicating an open competition. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $15,028.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 300 mg tablets in quantities of 500 per bottle. This is a firm-fixed-price delivery order contract with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...